CYP2E1 and metabolic dysfunction-associated steatotic liver disease: CYP2E1 can oxidize a variety of small-molecule substrates, including xenobiotics, ethanol, and fatty acids, producing superoxide anion, a very potent reactive oxygen species (ROS), which can serve as part of the second hit to advance the severity of NAFLD [48].